Search Orphan Drug Designations and Approvals
-
Generic Name: | nicotinamide riboside and pterostilbene |
---|---|
Date Designated: | 03/19/2018 |
Orphan Designation: | Treatment of Amyotrophic Lateral Sclerosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Elysium Health Inc. 434 Broadway Floor 2 New York, New York 10013 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-